These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6793057)

  • 1. Comparative effects of topical anthralin and difluoromethylornithine (alpha DFMO) on epidermal polyamine concentration in psoriasis.
    Henry M; Juillard J; Tell G; Schechter PJ; Grove J; Koch-Weser J; Grosshans E
    Br J Dermatol; 1981 Aug; 105 Suppl 20():33-4. PubMed ID: 6793057
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin polyamine levels in psoriasis: the effect of dithranol therapy.
    Bohlen P; Grove J; Beya MF; Koch-Weser J; Henry MH; Grosshans E
    Eur J Clin Invest; 1978 Aug; 8(4):215-8. PubMed ID: 100325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polyamines in psoriasis].
    Grosshans E; Henry M; Tell G; Schechter PJ; Böhlen P; Grove J; Koch-Weser J
    Ann Dermatol Venereol; 1980 May; 107(5):377-87. PubMed ID: 6784653
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylglyoxal BIS (guanylhydrazone) and alpha-difluoromethylornithine-induced polyamine deprivation in psoriatic lesions.
    Kousa M; Käpyaho K; Lauharanta J; Linnamaa K; Jänne J; Mustakallio K
    Acta Derm Venereol; 1982; 62(3):221-4. PubMed ID: 6179362
    [No Abstract]   [Full Text] [Related]  

  • 5. Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin.
    Lowe NJ; Ashton RE; Koudsi H; Verschoore M; Schaefer H
    J Am Acad Dermatol; 1984 Jan; 10(1):69-72. PubMed ID: 6693604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of steroid and dithranol therapy on cyclic nucleotides in psoriatic epidermis.
    Saihan EM; Albano J; Burton JL
    Br J Dermatol; 1980 May; 102(5):565-9. PubMed ID: 6248098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 'novel' action of anthralin.
    Lotti T; Brunetti L; Panconesi E
    Arch Dermatol; 1986 Jul; 122(7):748-9. PubMed ID: 3729504
    [No Abstract]   [Full Text] [Related]  

  • 8. A topical treatment program for psoriasis with low anthralin concentrations.
    Brody I; Johansson A
    J Cutan Pathol; 1977 Oct; 4(5):233-43. PubMed ID: 342554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of anthralin in skin during treatment.
    Juhlin L; Schroot B
    Acta Derm Venereol Suppl (Stockh); 1985; 120():27-9. PubMed ID: 3869415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of psoriasis with the Ingram anthralin paste regimen.
    Ross JB; Guptill J
    Can Med Assoc J; 1982 Mar; 126(5):496. PubMed ID: 7066806
    [No Abstract]   [Full Text] [Related]  

  • 11. Anthralin cream as short contact therapy for psoriasis.
    Miller AC
    Cutis; 1985 Jun; 35(6):578-82. PubMed ID: 4017653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthralin: historical and current perspectives.
    Ashton RE; Andre P; Lowe NJ; Whitefield M
    J Am Acad Dermatol; 1983 Aug; 9(2):173-92. PubMed ID: 6309924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of psoriasis vulgaris: gentleness to the entire psoriatic skin and the use of low concentrations of anthralin.
    Brody I
    Br J Dermatol; 1981 Aug; 105 Suppl 20():109-10. PubMed ID: 7284255
    [No Abstract]   [Full Text] [Related]  

  • 14. Lowered cutaneous and urinary levels of polyamines with clinical improvement in treated psoriasis.
    Proctor MS; Wilkinson DI; Orenberg EK; Farber EM
    Arch Dermatol; 1979 Aug; 115(8):945-9. PubMed ID: 464623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthralin therapy for psoriasis.
    Statham BN; Ryatt KS; Rowell NR
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 1):303-4. PubMed ID: 6480932
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidermal nicotinamide adenine dinucleotides in psoriasis during treatment with dithranol.
    Hammar H
    Arch Dermatol Forsch; 1975; 252(3):229-36. PubMed ID: 239644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Topical treatment of psoriasis].
    Suhonen R
    Duodecim; 1985; 101(11):1135-41. PubMed ID: 4017905
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased cytotoxicity of cis-diamminedichloroplatinum(II) by alpha-difluoromethylornithine depletion of polyamines in 9L rat brain tumor cells in vitro.
    Oredsson SM; Deen DF; Marton LJ
    Cancer Res; 1982 Apr; 42(4):1296-9. PubMed ID: 6800651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the use of anthralin.
    Seville RH
    J Am Acad Dermatol; 1981 Sep; 5(3):319-21. PubMed ID: 7263977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disappearance of psoriactic lesions under the effect of anthralin].
    Chowaniec O
    Przegl Dermatol; 1976; 63(5):665-71. PubMed ID: 1005760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.